| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.24 | 7e-12 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0001 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0005 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.099 | 0.0007 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0008 |